Pharmacists in Memphis, Tennessee
1144 Pharmacists found in Memphis
May Trezevant, PHARMD
Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
1030 Jefferson Ave, Memphis, TN 38104
901-523-8990
Megan Wright, PHARMD
Pharmacist - Pharmacotherapy
262 Danny Thomas Pl, Memphis, TN 38105
901-595-4201
Dr. Meghan Grace Vail, PHARMD
Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
6019 Walnut Grove Rd, Memphis, TN 38120
901-226-5000
Dr. Melanie Parnell Swims, PHARM.D.
Pharmacist - Pharmacotherapy
1030 Jefferson Ave, Memphis, TN 38104
901-523-8990 901-577-7306
Dr. Melanie Bangerter Belcher, PHARM.D.
Pharmacist
2525 Horizon Lake Dr, Ste 101, Memphis, TN 38133
877-882-7820
Dr. Melanie Ann Joyner-huggins, PHARMD
Pharmacist
1863 Union Ave, Memphis, TN 38104
901-272-2006 901-725-0021
Dr. Melissa Yau Gray, PHARMD
Pharmacist
1620 Century Center Pkwy, Suite 101, Memphis, TN 38134
901-385-3600
Dr. Melissa Keeton Montgomery, PHARM.D.
Pharmacist
2525 Horizon Lake Dr Ste 101, Memphis, TN 38133
877-882-7822 901-384-9936
Melissa Tucker-talbert
Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
2835 Kirby Rd, Memphis, TN 38119
901-353-1387
Ms. Melissa Juanita Dossey, D.PH.
Pharmacist
1640 Century Center Pkwy, Suite 101, Memphis, TN 38134
901-385-3600
Dr. Melissa Williams Greene, PHARM.D.
Pharmacist
1620 Century Center Pkwy, Memphis, TN 38134
901-385-3600
Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.